Robbins LLP is Investigating Allegations that Aehr Test Systems, Inc. (AEHR) Failed to Disclose Delays in Customer Orders

Robbins LLP informs investors that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Aehr Test Systems, Inc. (NASDAQ: AEHR) securities between January 9, 2024 and March 24, 2024. Aehr provides test solutions for testing, burning-in, and semiconductor devices in wafer level, singulated die, and package part form, and installed systems worldwide.  

The Allegations     

According to the complaint, during the class period, defendants failed to disclose that contrary to prior representations to investors, Aehr was continuing to experience substantial delays in customer orders, which was likely to have a material negative impact on the Company's revenue growth, and therefore, the Company's business and/or financial prospects were overstated. The complaint alleges that when Aehr announced its disappointing preliminary fiscal Q3 2024 financial results on March 5, 2024, the Company's stock fell over 22%, to close at $11.37 per share on March 25, 2024.

What Now: You may be eligible to participate in the class action against Aehr Test Systems, Inc. Shareholders who want to serve as lead plaintiff for the class must submit their application to the court by February 3, 2025. A lead plaintiff is a representative party who acts on behalf of other class members in directing the litigation.  You do not have to participate in the case to be eligible for a recovery. If you choose to take no action, you can remain an absent class member.

All representation is on a contingency fee basis. Shareholders pay no fees or expenses.